Relay Therapeutics, Inc.
Relay Therapeutics, Inc.（RLAY）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
rlay · 股价预测 · 15 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 15 位华尔街分析师
Buy
15 位分析师
共识
评级分布
12 个月目标价
High
$28.00
Consensus
$24.00
+73.2% upside
Low
$18.00
Median: $26 · Last Close: $13.86
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$24.00
73.2% upside
High Target
$28
102.0%
Low Target
$18
29.9%
Current Price
$13.86
as of today
Based on analyst price targets, the RLAY stock price prediction for the next 12 months ranges from $18 to $28. The consensus RLAY price forecast of $24.00 implies 73.2% upside from the current price of $13.86.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $14.55 | ↑ 5.00% |
1-day model range: $14.43–$14.67. Peak: $14.67 (+5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $15 | +4.9% |
| 2028 | $15 | +8.0% |
| 2029 | $15 | +9.9% |
| 2030 | $15 | +11.0% |
| 2031 | — | +11.7% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · RLAY · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-26 | Guggenheim | Maintains | Buy→Buy |
| 2026-05-20 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-05-20 | Barclays | Maintains | Overweight→Overweight |
| 2026-05-19 | Raymond James | Maintains | Strong Buy→Strong Buy |
| 2026-04-29 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-28 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-04-28 | Goldman Sachs | Maintains | Buy→Buy |
| 2026-04-28 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-04-28 | Wells Fargo | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Relay Therapeutics, Inc. (RLAY) stock. Of the recent 86 rating actions, 6 were upgrades and 1 were downgrades. 15 analysts currently cover RLAY.
分析师推荐趋势
RLAY analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 5 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$12M
↓ 78.5% YoY
Revenue Next Year
$20M
↑ 65.2% YoY
EPS This Year
$-1.57
EPS Next Year
$-1.62
↑ 3.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast RLAY EPS of $-1.57 for the current fiscal year, based on estimates from 8 analysts. The RLAY revenue forecast is $12M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
RLAY 股价预测由两类独立数据源支撑：来自 15 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。RLAY 的共识目标价为 $24.00（+73.2% 上行空间），分析师共识为 Buy。
RLAY 的短期预测（明日）为 $14.55（+5.00%）。 RLAY 对 2027 年的股价预测均值为 $15。 RLAY 对 2030 年的预测区间为 $14–$17。
Relay Therapeutics, Inc. 在 NASDAQ 上市，代码 RLAY。RLAY 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
RLAY 预测 · 8 个问题根据 15 位华尔街分析师，RLAY 的 12 个月平均目标价为 $24.00，最高 $28.00、最低 $18.00。若有图表，中位目标价可在上方查看。相对当前价 $13.86，隐含约 +73.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.